Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
9/10/2024 | $3.00 | Buy | Lake Street |
3/29/2023 | $2.25 | Neutral | UBS |
11/29/2022 | $4.50 | Outperform | Oppenheimer |
10/4/2022 | $9.50 | Buy | B. Riley Securities |
12/17/2021 | $7.00 | Neutral | UBS |
4 - Butterfly Network, Inc. (0001804176) (Issuer)
4 - Butterfly Network, Inc. (0001804176) (Issuer)
4 - Butterfly Network, Inc. (0001804176) (Issuer)
8-K - Butterfly Network, Inc. (0001804176) (Filer)
424B5 - Butterfly Network, Inc. (0001804176) (Filer)
424B5 - Butterfly Network, Inc. (0001804176) (Filer)
Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly") a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will present and host one-on-one investor meetings at the TD Cowen 45th Annual Health Care Conference in Boston on March 3, 2025. Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one meetings and will present a business overview at 1:10pm EST. A webcast of the presentation will be available in the Events & Presentations section of the Butterfly investor website. About Butterfly Network Butterfly Network, Inc. (NYSE:BFLY) is a healthcare company driving a digital revo
Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2024 financial results on Friday, February 28, 2025, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast before the market opens on February 28 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly
Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced the pricing of an underwritten public offering of 24,000,000 shares of its Class A common stock (the "Common Stock"), at a public offering price of $3.15 per share. The gross proceeds to Butterfly from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $75.6 million. Butterfly has granted the underwriters a 30-day option to purchase up to an additional 3,600,000 shares of Common Stock at the public offering
Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2024 financial results on Friday, February 28, 2025, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast before the market opens on February 28 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly
Delivered Quarterly Revenue of $20.6mm, 33% YoY Growth Raises Full Year Revenue and Adjusted EBITDA Guidance Delivered quarterly Revenue of $20.6 million in Q3, representing 33% YoY growth Reduced Q3 Net Loss by 38% and Net Cash Used in Operations by 50% Launched iQ3 in Europe and opened new markets in Indonesia, the Netherlands, and Belgium Announced the formation of Octiv™, a wholly owned subsidiary focused on bringing Butterfly's chip to new sectors Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for th
Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report third quarter 2024 financial results on November 1, 2024 at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host a conference call and webcast before the market opens on November 1 to discuss third quarter 2024 financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor
Lake Street initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00
UBS initiated coverage of Butterfly Network with a rating of Neutral and set a new price target of $2.25
Oppenheimer initiated coverage of Butterfly Network with a rating of Outperform and set a new price target of $4.50
4 - Butterfly Network, Inc. (0001804176) (Issuer)
4 - Butterfly Network, Inc. (0001804176) (Issuer)
4 - Butterfly Network, Inc. (0001804176) (Issuer)
SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)
SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)
SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)
Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial Momentum Butterfly Network, Inc. (NYSE:BFLY), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced the appointment of Steve Cashman as Chief Business Officer (CBO), effective today. Cashman joins Butterfly at an exciting juncture, following the Company's successful launch of its third-generation Butterfly iQ3 and historic revenue performance in the first half of 2024. Cashman will join Butterfly's Executive Management Team, overseeing the Company's global sales, marketing, product and corporate strategy. This press release f
SAN FRANCISCO, Aug. 20, 2024 /PRNewswire/ -- Avive Solutions, Inc., a manufacturer of innovative Automated External Defibrillators (AEDs) and software solutions to improve access to AEDs and response to cardiac arrest emergencies, is excited to announce the appointment of Katerina Miras as their Vice President of Marketing. A visionary marketing leader with extensive experience in medtech, Miras brings a wealth of expertise in creating memorable healthcare brands that accelerate commercial growth. "I am honored to join Avive's leadership team at such a transformative time for
Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors. Ms. Getz brings more than 25 years of corporate experience creating long-term value through financial, general management, and healthcare leadership. She has significant expertise in finance, reimbursement, investor relations, compliance, M&A and strategic plannin